Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Keklik Karadağ, Fatma"'
Autor:
Yiğit Kaya, Süreyya, Mutlu, Yaşa Gül, Malkan, Ümit Yavuz, Mehtap, Özgür, Keklik Karadağ, Fatma, Korkmaz, Gülten, Elverdi, Tuğrul, Saydam, Güray, Özet, Gülsüm, Ar, Muhlis Cem, Melek, Elif, Maral, Senem, Kaynar, Leylagül, Sevindik, Ömür Gökmen
Publikováno v:
In Leukemia Research May 2024 140
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Karakuş, Volkan, Aslan, Vedat, Parça, Güleycan, Sevindik, Ömür Gökmen, Keklik Karadağ, Fatma, Kurtoğlu, Erdal, Saydam, Güray
Publikováno v:
Blood. 140:12236-12237
Per WHO 2016 and 2022 (5th ed.) myeloproliferative disease guidelines, Chronic Myeloid Leukemia (CML) is classified under two major groups according to the presence of bcr-abl translocation; these groups require different treatment approaches and sho
Autor:
Cavazos, Karla, Eswaran, Sheila, Maidlow, Cathleen, Keklik Karadag, Fatma, Idilman, Ramazan, Idilman, Ilkay, Miller, Ira, Shammo, Jamile, Reau, Nancy, Ustun, Celalettin
Publikováno v:
In Blood Advances 25 October 2022 6(20):5630-5633
Periferik T cell Lenfomalı Hastalarda Belinostat Deneyimi; Çok Merkezli Gerçek Yaşam Verisi, Türkiye
Autor:
AKDENİZ, Aydan, KEKLİK KARADAĞ, Fatma, ATALAY, Figen, DEVECİ, Burak, MİSKİOĞLU, Mine, AYTAN, Pelin, SAYDAM, Guray
Publikováno v:
Volume: 44, Issue: 4 454-459
Osmangazi Tıp Dergisi
Osmangazi Tıp Dergisi
T-cell lymphoma (PTHL) is a rare and aggressive subtype of non-Hodgkin lymphomas. The prognosis is poor in all subgroups except for ALK-positive anaplastic large cell lymphoma. In recent years, the use of targeted therapies in patients with relapse-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=tubitakulakb::bc21f4bb44875c7b35a275f17a9d038e
https://dergipark.org.tr/tr/pub/otd/issue/70294/1038937
https://dergipark.org.tr/tr/pub/otd/issue/70294/1038937
Autor:
Demirci, Ufuk, Kırkızlar, Hakkı Onur, Ümit, Elif G., Gürsoy, Vildan, Pınar, İbrahim Ethem, Özkalemkaş, Fahir, Güven, Zeynep Tuğba, Kaynar, Leylagül, Keklik Karadağ, Fatma, Saydam, Güray, Ekinci, Ömer, Merter, Mustafa, Aras, Merih Reis, Albayrak, Murat, Gülsaran, Sedanur Karaman, Baş, Volkan, Aydın, Berrin Balık, Beköz, Hüseyin Saffet, Can, Ferda, Dilek, İmdat
Publikováno v:
Journal of Hematopathology; Dec2022, Vol. 15 Issue 4, p203-213, 11p
Autor:
ŞAHİN, FAHRİ, AKSU, SALİH, AYDIN KAYNAR, LALE, ÜSKÜDAR TEKE, HAVA, KEKLİK KARADAĞ, FATMA, Yenerel, Mustafa Nuri, YILMAZ, MEHMET, ÖZKOCAMAN, VİLDAN, Tuglular, Tulin Firatli, ERDEM, Fuat, Ayyildiz, Orhan, Ozet, Gulsum, Comert, Melda, KAYA, EMİN, Ayer, Mesut, SALİM, OZAN, GÜVENÇ, BİROL, Ozdogu, Hakan, ÜNAL, ALİ, MEHTAP, ÖZGÜR, SÖNMEZ, MEHMET, Guler, Nil, Hacioglu, Sibel, AYDOĞDU, İSMET, BEKTAŞ, ÖZLEN, TOPRAK, SELAMİ KOÇAK, Yagci, Munci, TOMBAK, ANIL, Karakus, Volkan, YAVAŞOĞLU, İRFAN, ÖNEÇ, BİRGÜL, ÖZCAN, MEHMET ALİ, ÜNDAR, LEVENT, ALİ, RIDVAN, İLHAN, OSMAN, SAYDAM, GÜRAY
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare X-linked genetic disorder. On the contrary to its name, it is a multisystemic disease and various symptoms other than hemoglobinuria could be occurred. It could be life threatening especially becaus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b4d822f7f7138abd8b27c1925c16a0f4
https://avesis.erciyes.edu.tr/publication/details/ee8beafb-d055-406a-8781-82fb780274d8/oai
https://avesis.erciyes.edu.tr/publication/details/ee8beafb-d055-406a-8781-82fb780274d8/oai
Autor:
Keklik Karadağ, Fatma
Amaç: Hemofili A ve B sırasıyla Faktör 8 ve Faktör 9 eksikliği nedeni ile görülen X e bağlı resesif kalıtım gösteren kanama bozukluklarıdır. Faktör replasmanı ve yeni tedavi ajanlarının kullanıma girmesi ile Hemofili hastalarını
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10208::e4d602d9d1625de15dbd7c75bea27468
https://acikbilim.yok.gov.tr/handle/20.500.12812/334506
https://acikbilim.yok.gov.tr/handle/20.500.12812/334506
Autor:
Keklik Karadağ F; Department of Hematology, Izmir City Hospital, Izmir, TUR., Gunes A; Department of Internal Medicine, Division of Hematology, Ege University Faculty of Medicine, Izmir, TUR., Mete Gokmen N; Department of Internal Medicine, Division of Allergy and Immunology, Ege University Faculty of Medicine, Izmir, TUR., Şahin F; Department of Internal Medicine, Division of Hematology, Ege University Faculty of Medicine, Izmir, TUR., Saydam G; Department of Internal Medicine, Division of Hematology, Ege University Faculty of Medicine, Izmir, TUR.
Publikováno v:
Cureus [Cureus] 2024 Aug 06; Vol. 16 (8), pp. e66310. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).
Autor:
Tekinalp A; Necmettin Erbakan University Meram Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye, Gedük A; Kocaeli University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Kocaeli, Türkiye, Akdeniz A; Mersin University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Mersin, Türkiye, Terzi Demirsoy E; University of Health Sciences Türkiye, Derince Training and Research Hospital, Clinic of Hematology, Kocaeli, Türkiye, Gürsoy V; Bursa City Hospital, Clinic of Hematology, Bursa, Türkiye, Aslaner Ak M; Bülent Ecevit University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Zonguldak, Türkiye, Bağcı M; Selçuk University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye, Seçilmiş S; Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Hematology, Ankara, Türkiye, Keklik Karadağ F; Ege University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, İzmir, Türkiye, Oruç Uysal A; Fırat University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Elazığ, Türkiye, Doğan A; Van Yüzüncü Yıl University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Van, Türkiye, Demircioğlu S; Necmettin Erbakan University Meram Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye, Erol HA; Kocaeli University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Kocaeli, Türkiye, Aslan C; University of Health Sciences Türkiye, Derince Training and Research Hospital, Clinic of Hematology, Kocaeli, Türkiye, Özkalemkaş F; Bursa Uludağ University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Bursa, Türkiye, Ertop Ş; Bülent Ecevit University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Zonguldak, Türkiye, Dağlı M; Selçuk University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye, Dal MS; Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Hematology, Ankara, Türkiye, Saydam G; Ege University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, İzmir, Türkiye, Merter M; Fırat University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Elazığ, Türkiye, Ural C; Van Yüzüncü Yıl University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Van, Türkiye, Çeneli Ö; Necmettin Erbakan University Meram Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 Dec 05; Vol. 40 (4), pp. 242-250. Date of Electronic Publication: 2023 Nov 14.